News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
1281
Sources here
12
Companies here
19
Search results Stored financial headlines

Active search

1281 matching headlines

Ticker or company: BBMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

What BBB Foods' Long Growth Runway Means, and Why a Director's Latest Insider Transaction Doesn't Detract From It

Rose Nicole Dominique Reich Sapire, a director at BBB Foods Inc. (NYSE:TBBB), disposed of 4,754 shares of Class A Common Shares on August 7, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$193,345 Shares sold 4,754 Post-transaction shares …

TBBBN main company TBBB main company
Sharemaestro market context Trend signal active 52 weeks +69.6% TBBBN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Here's How to Read BBB Foods' Latest Insider Filings as Chain Grows 39% Despite Soft Economy

Juan Pablo Cappello, a director at BBB Foods Inc. (NYSE:TBBB), reported the disposition of 7,660 shares valued at $312,000 on August 7, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$312,000 Shares sold 7,660 Post-transaction shares (directly held) 97,295 …

TBBBN main company TBBB main company
Sharemaestro market context Trend signal active 52 weeks +69.6% TBBBN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BBB Foods Shows a Net Loss but Its Cash Flow Surged. Here's How to Read an Insider's Trade Before Last Week's Earnings

Sami Gabriel Khouri, a director at BBB Foods Inc. (NYSE:TBBB), disclosed a non-discretionary disposition of 14,101 Class A Common Shares on August 7, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$573,500 Shares sold 14,101 Post-transaction shares (total) ~3.6 …

TBBBN main company TBBB main company
Sharemaestro market context Trend signal active 52 weeks +69.6% TBBBN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year

For years, AbbVie (NYSE: ABBV) was known primarily for immunology. Humira built the company into a pharmaceutical giant, and newer blockbusters Skyrizi and Rinvoq have helped replace much of the revenue lost to biosimilar competition. Now the company's got another iron in the fire …

ABBV main company ABBV main company ABBV34 main company ABBV main company ABBV main company
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

4,055 Shares in Chubb Limited $CB Bought by One Wealth Advisors LLC

One Wealth Advisors LLC recently acquired 4,055 shares of Chubb Limited, valued at approximately $1.38 million. This purchase is part of broader institutional investment in Chubb, with hedge funds and other institutional investors collectively owning 83.81% of the company's stock. Chubb reported strong quarterly …

CB main company
Sharemaestro market context Trend signal active 52 weeks +25.3% · Next-week setup positive 59.2% CB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(RBB) and the Role of Price-Sensitive Allocations

This article provides an AI-generated analysis of Rbb Bancorp (NYSE: RBB), indicating a strong near-term sentiment that may lead to a long-term positive bias. It highlights a mid-channel oscillation pattern and presents three institutional trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, complete …

RBB main company
Sharemaestro market context Trend signal active 52 weeks +37.8% RBB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV

Synergy Asset Management LLC significantly increased its stake in AbbVie Inc. (NYSE:ABBV) by 703.9% in the second quarter, bringing its total holdings to 180,179 shares valued at $45.34 million. AbbVie now represents 4.3% of Synergy's portfolio, with other major institutional investors also adjusting their …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Southeast Asset Advisors, LLC's Hubbell Inc(HUBB) Holding History

This article details Southeast Asset Advisors, LLC's investment in Hubbell Inc (HUBB) as of June 30, 2026. The firm holds 5,711 shares valued at $2.99 million, representing 0.3% of its portfolio. With an average purchase price of $504.83 per share and a current price …

HUBB main company
Sharemaestro market context Price above Trend Line 52 weeks +17.4% · Next-week setup positive 56.1% HUBB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Royal Caribbean Officially Welcomes Legend of the Seas to the Revolutionary Icon Class, Built in Collaboration With Meyer Turku

Royal Caribbean officially welcomed the Legend of the Seas, the third Icon Class ship, built in collaboration with Meyer Turku. The ship, which is LNG-powered, will debut in Europe in July 2026 for Western Mediterranean cruises before heading to Fort Lauderdale in November for …

RCL main company
Sharemaestro market context Trend signal active 52 weeks -10.0% RCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AbbVie Defends Its Turf, But Leaves One Big Question Open

AbbVie (ABBV) is performing strongly, with its stock up and sales growth beating expectations, though its EPS guidance was slightly trimmed due to an acquisition. While the company successfully defended its SKYRIZI sales against new competition, analysts are still concerned about its future pipeline …

ABBV main company ABBV main company ABBV34 main company ABBV main company ABBV main company
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Bristol Myers Squibb (NYSE:BMY) is facing a revived US$6.7b lawsuit after a federal appeals court reinstated claims tied to its Celgene acquisition. Plaintiffs allege the …

BMY main company BMY main company BMY main company BMYS main company BRM main company
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AbbVie (ABBV) Stock May Trade At A Premium Despite Cash Flow Upside

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AbbVie stock has delivered a strong 152.2% return over the past 5 years, yet the valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value …

ABBV main company ABBV main company ABBV34 main company ABBV main company ABBV main company
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

45,829 Shares in RBB Bancorp $RBB Bought by Walleye Capital LLC

Walleye Capital LLC recently acquired 45,829 shares of RBB Bancorp (NASDAQ:RBB) for approximately $1.26 million, marking a new position for the firm. This acquisition is part of broader institutional investment, with hedge funds and other investors owning over 40% of the company. RBB Bancorp …

RBB main company
Sharemaestro market context Trend signal active 52 weeks +37.8% RBB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oppenheimer Asset Management Inc. Buys New Shares in Chubb Limited $CB

Oppenheimer Asset Management Inc. acquired 118,585 shares of Chubb Limited, valued at approximately $40.4 million, during the second quarter. Institutional investors hold 83.81% of Chubb's stock, while corporate insiders own 0.37%. The company recently exceeded earnings expectations, reporting $7.26 EPS against a $6.77 estimate, …

CB main company
Sharemaestro market context Trend signal active 52 weeks +25.3% · Next-week setup positive 59.2% CB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mill Capital Management LLC Makes New Investment in Chubb Limited $CB

Mill Capital Management LLC recently invested in Chubb Limited (NYSE:CB), purchasing 3,210 shares valued at $1.09 million in Q2. Institutional investors and hedge funds now own 83.81% of the company. Despite recent insider share sales, Chubb reported strong quarterly earnings, beating consensus estimates, and …

CB main company
Sharemaestro market context Trend signal active 52 weeks +25.3% · Next-week setup positive 59.2% CB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northstar Group Inc. Takes $1.72 Million Position in Chubb Limited $CB

Northstar Group Inc. has acquired a new position in Chubb Limited (NYSE:CB), purchasing 5,032 shares valued at approximately $1.72 million during the second quarter. Chubb recently reported strong quarterly earnings of $7.26 per share, exceeding analyst estimates, and declared a quarterly dividend of $1.02 …

CB main company
Sharemaestro market context Trend signal active 52 weeks +25.3% · Next-week setup positive 59.2% CB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Park National Corp OH Lowers Stake in Abbott Laboratories $ABT

Park National Corp OH reduced its stake in Abbott Laboratories by 10.2% in the second quarter, selling 17,000 shares but still retaining 150,182 shares valued at approximately $13.6 million. Despite this reduction and some analysts lowering price targets, the consensus rating for Abbott remains …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context